Multifield brachytherapy for multifocal retinoblastoma
##article.numberofdownloads## 81
##article.numberofviews## 163
pdf (Русский)

Keywords

multifocal retinoblastoma
multifield brachytherapy
106Ru
90Sr

How to Cite

Kotova , E., Yarovoy, . A., Golanov, . A., Ushakova , T., & Yarovaya , V. (2022). Multifield brachytherapy for multifocal retinoblastoma. Voprosy Onkologii, 68(4), 481–488. https://doi.org/10.37469/0507-3758-2022-68-4-481-488

Abstract

Multifocal retinoblastoma (RB) is the most severe course variant of this disease, the incidence among patients with binocular RB is 67-70%. Despite the high rates occurrence of this form in clinical practice, there is no information in the literature about the efficacy of its treatment using brachytherapy (BT) and various modifications (multifield BT, simultaneous using of two plaques). The safety of repeated irradiation is unexplored.

The aim of the study is to evaluate the efficacy of multifield BT in the treatment of multifocal RB.

Materials and methods: in the period from 2007 to 2021 BT was used as a local treatment for RB in 136 patients (146 eyes), among them 42 patients (46 eyes – 106 tumors) with multifocal RB were treated by multifield BT. The mean age at the time of treatment was 26.8 months (range, 6-67 months). Irradiation was performed in the following variants: from two fields – 36 eyes, from three fields – 8 eyes, from four fields – 1 eye, from five fields – 1 eye. BT with simultaneous using of two plaques in different parts of the fundus was performed in 6 patients (6 eyes), BT with sequential displacement plaque to the neighbouring or the opposite zone - in 15 patients (15 eyes).

Results: complete tumor regression was achieved in 70% (n=74), partial tumor regression - in 22% (n=23). Progressive disease was observed in 7% (n=8), tumor recurrence in 4 months after BT - in 1% (n=1). Local control of the tumor was achieved in 92% of cases. The only eyes were preserved in 90% of cases. BT-related complications were observed in 48% of cases (22 eyes) with mean follow-up 55 months (range, 3-157 months). A comparative analysis efficacy of multifield BT and single-field BT was performed additionally, as a result was shown that multifield BT allows to achieve a comparable tumor local control (94%; p= 0.128) with a clearly greater number of BT-related complications (46%; p=0.02), which does not significantly affect the eye-retention rate of the treatment (83%; p=0.16).

Conclusion: multifield BT has shown high efficacy and relative safety in the treatment of patients with multifocal RB.

 

https://doi.org/10.37469/0507-3758-2022-68-4-481-488
##article.numberofdownloads## 81
##article.numberofviews## 163
pdf (Русский)

References

Горовцова О.В., Ушакова Т.Л., Поляков В.Г. Современные возможности органосохраняющего лечения детей с интраокулярной ретинобластомой // Онкопедиатрия. 2018;5(3):175–187 [Gorovtsova OV, Ushakova TL, Polyakov VG. Modern Possibilities of Organ-Preserving Treatment in Children with Intraocular Retinoblastoma // Onkopediatriya. 2018;5(3):175–187 (In Russ.)]. doi:10.15690/onco.v5i3.1935

Саакян С.В. Современные подходы к лечению ретинобластомы // Российский офтальмологический журнал. 2008;1(1):33–38 [Saakyan SV. Sovremennye podkhody k lecheniyu retinoblastomy // Rossiiskii oftal'mologicheskii zhurnal. 2008;1(1):33–38 (In Russ.)].

Яровой А.А., Булгакова Е.С., Кривовяз О.С. и др. Эффективность брахитерапии при ретинобластоме // Офтальмохирургия. 2016;(1):52–58 doi:10.25276/0235-4160-2016-1-52-58 [Yarovoy AA, Bulgakova ES, Krivovyaz OS et al. The efficiency of plaque radiotherapy in the management of retinoblastoma // Fyodorov Journal of Ophthalmic Surgery. 2016;(1):52–58 (In Russ.)]. doi:10.25276/0235-4160-2016-1-52-58

Moore RF, Stallard HB, Milner JG. Retinal gliomata terated by radon seeds // Br. J. Ophthalmol. 1931;15(12):673–696. doi:10.1136/bjo.15.12.673

Яровой А.А., Кривовяз О.С., Горовцова О.В. и др. Роль локальных методов в системе органосохраняющего лечения интраокулярной ретинобластомы // Вестник РОНЦ им. Н.Н. Блохина РАМН. 2015;26(2):15–22 [Yarovoy AA, Krivovyaz OS, Gorovtsova OV et al. The role of local methods in the organ-preserving treatment of intraocular retinoblastoma // Vestnik RONC im. N.N. Blokhina RAMN. 2015;26(2):15–22 (In Russ.)].

Саакян С.В., Вальский В.В. Эффективность брахитерапии в комплексном лечении ретинобластомы // Альманах клинической медицины. 2018;46(2):132–136 doi:10.18786/2072-0505-2018-46-2-132-136 [Saakyan SV, Valskiy VV. Effectiveness of brachytherapy in the combination treatment of retinoblastoma // Almanakh klinicheskoii meditsiny. 2018;46(2):132–136 (In Russ.)]. doi:10.18786/2072-0505-2018-46-2-132-136

Simpson ER, Gallie B, Laperrierre N et al. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma // Brachytherapy. 2014;13(1):1–14. doi:10.1016/j.brachy.2013.11.008

Яровой А.А., Яровая В.А., Котова Е.С. и др. Брахитерапия ретинобластомы: результаты 13 лет применения // Злокачественные опухоли. 2021;11(2):5–12 doi:10.18027/2224-5057-2021-11-2-5-12 [Yarovoy AA, Yarovaya VA, Kotova ES et al. Brachytherapy for retinoblastoma: a 13 year experience // Zlokachestvennye opukholi. 2021;11(2):5–12 (In Russ.)]. doi:10.18027/2224-5057-2021-11-2-5-12

Яровой А.А., Ушакова Т.Л., Поляков В.Г. и др. Результаты локального лечения ретинобластомы при недостаточной эффективности полихимиотерапии // Офтальмохирургия. 2014;(1):79–84 [Yarovoy A.A, Ushakova T.L, Polyakov V.G et al. Results of local treatment of retinoblastoma after polychemotherapy // Fyodorov Journal of Ophthalmic Surgery. 2014;(1):79–84 (In Russ.)].

Dunphy EB. The story of retinoblastoma // Trans Am. Acad. Ophthalmol. Otolaryngol. 1964;68):249–264.

Яровой А.А., Клеянкина C.C., Зубарева С.А. и др. Ретробульбарная инфузионная терапия интраокулярных осложнений локального лечения ретинобластомы // Российская детская офтальмология. 2020(2):26–30 doi:10.25276/2307-6658-2020-2-26-30 [Yarovoy А.А, Kleyankina S.S, Zubareva S.А et al. Retrobulbar Infusion Therapy of Intraocular Complications of Local Treatment of Retinoblastoma // Rossiiskaya detckaya oftal’mologiya. 2020(2):26–30 (In Russ.)]. doi:10.25276/2307-6658-2020-2-26-30

Yarovoy AA, Ushakova TL, Gorshkov IM et al. Intraocular Surgery with Melphalan Irrigation for Vitreous Hemorrhage in an Only Eye with Retinoblastoma // Eur. J. Ophthalmol. 2016;26(1):17–19. doi:10.5301/ejo.5000683

Яровой А.А., Горшков И.М., Ушакова Т.Л. и др. Хирургическое лечение гемофтальма с одновременной ирригацией мелфалана у пациентов с ретинобластомой // Российская детская офтальмология. 2020(2):20–25 doi:10.25276/2307-6658-2020-2-20-25 [Yarovoy АА, Gorshkov IM, Ushakova TL et al. Surgical Treatment with Simultaneous Melphalan Irrigation for Vitreous Haemorrhage in Patients with Retinoblastoma // Rossiiskaya detckaya oftal’mologiya. 2020(2):20–25 (In Russ.)]. doi:10.25276/2307-6658-2020-2-20-25

Abouzeid H, Moeckli R, Gaillard M-C et al. 106Ruthenium Brachytherapy for Retinoblastoma // Int. J. Radiat. Oncol. 2008;71(3):821–828. doi:10.1016/j.ijrobp.2007.11.004

Murakami N, Suzuki S, Ito Y et al. 106Ruthenium Plaque Therapy (RPT) for Retinoblastoma // Int. J. Radiat. Oncol. 2012;84(1):59–65. doi:10.1016/j.ijrobp.2011.11.002

Schueler AO, Flühs D, Anastassiou G et al. Beta-Ray Brachytherapy of Retinoblastoma: Feasibility of a New Small-Sized Ruthenium-106 Plaque // Ophthalmic Res. 2006;38(1):8–12. doi:10.1016/j.ijrobp.2006.02.002

Schueler AO, Flühs D, Anastassiou G et al. β-Ray brachytherapy with 106Ru plaques for retinoblastoma // Int. J. Radiat. Oncol. 2006;65(4):1212–1221. doi:10.1159/000088259

Клинические рекомендации: Интраокулярная ретинобластома, 2020 [Электронный ресурс]: http://www.oncology.ru/specialist/treatment/references/actual/71.pdf (дата обращения 03.02.2022) [Klinicheskie rekomendatsii: Intraokulyarnaya retinoblastoma. 2020 [Electronic resource]: http://www.oncology.ru/specialist/treatment/references/actual/71.pdf (appeal date 03.02.2022) (In Russ.)].

Echegaray JJ, Al-Zahrani YA, Singh A. Episcleral brachytherapy for retinoblastoma // Br. J. Ophthalmol. 2020;104(2):208–213. doi:10.1136/bjophthalmol-2019-313985

Shields CL, Shields JA, De Potter P et al. Plaque Radiotherapy in the Management of Retinoblastoma // Ophthalmology. 1993;100(2):216–224. doi:10.1016/j.ophtha.2006.04.032

Sohajda Z, Damjanovich J, Bardi E et al. Combined Local Treatment and Chemotherapy in the Management of Bilateral Retinoblastomas in Hungary // J. Pediatr. Hematol. Oncol. 2006;28(6):399–401. doi:10.1097/00043426-200606000-00016

Саакян С.В., Вальский В.В., Иванова О.А. Роль брахитерапии в комплексном лечении ретинобластомы // Съезд офтальмологов России, 10-й Сб. науч. мат. 2015):214 [Saakyan SV, Val'skii VV, Ivanova OA. Rol' brakhiterapii v kompleksnom lechenii retinoblastomy // S"ezd oftal'mologov Rossii, 10-i Sb. nauch. mat. 2015. S. 214 (In Russ.)].

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2022